Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blood–brain barrier link to human cognitive impairment and Alzheimer’s disease
Giuseppe Barisano, Axel Montagne, Kassandra Kisler, et al.
Nature Cardiovascular Research (2022) Vol. 1, Iss. 2, pp. 108-115
Open Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Jian Sheng Loh, Wen Qi Mak, Li Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 202
Progression of cerebral amyloid angiopathy: a pathophysiological framework
Emma A. Koemans, Jasmeer P. Chhatwal, Susanne J. van Veluw, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 7, pp. 632-642
Closed Access | Times Cited: 84
Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications
Jonas Cerneckis, Hongxia Cai, Yanhong Shi
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 56
Pericytes in the disease spotlight
Hielke van Splunder, Pilar Villacampa, Anabel Martínez-Romero, et al.
Trends in Cell Biology (2023) Vol. 34, Iss. 1, pp. 58-71
Open Access | Times Cited: 55
Activation of aryl hydrocarbon receptor (AhR) in Alzheimer’s disease: role of tryptophan metabolites generated by gut host-microbiota
Antero Salminen
Journal of Molecular Medicine (2023) Vol. 101, Iss. 3, pp. 201-222
Open Access | Times Cited: 53
Blood phosphorylated Tau181 reliably differentiates amyloid‐positive from amyloid‐negative subjects in the Alzheimer's disease continuum: A systematic review and meta‐analysis
Annibale Antonioni, Emanuela Maria Raho, Lamberto Manzoli, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 5
Nutrition Strategies Promoting Healthy Aging: From Improvement of Cardiovascular and Brain Health to Prevention of Age-Associated Diseases
Mónika Fekete, Z Szarvas, Vince Fazekas‐Pongor, et al.
Nutrients (2022) Vol. 15, Iss. 1, pp. 47-47
Open Access | Times Cited: 60
siRNA drug delivery across the blood–brain barrier in Alzheimer's disease
Muhammad Imran Sajid, Fahad Sultan Sheikh, Faiza Anis, et al.
Advanced Drug Delivery Reviews (2023) Vol. 199, pp. 114968-114968
Closed Access | Times Cited: 23
Freshwater Cyanobacterial Toxins, Cyanopeptides and Neurodegenerative Diseases
Galina Nugumanova, Eugene D. Ponomarev, Sholpan Askarova, et al.
Toxins (2023) Vol. 15, Iss. 3, pp. 233-233
Open Access | Times Cited: 22
Young blood-mediated cerebromicrovascular rejuvenation through heterochronic parabiosis: enhancing blood-brain barrier integrity and capillarization in the aged mouse brain
Rafał Gulej, Ádám Nyúl‐Tóth, Boglarka Csik, et al.
GeroScience (2024) Vol. 46, Iss. 5, pp. 4415-4442
Open Access | Times Cited: 14
Blood-brain barrier disruption: a culprit of cognitive decline?
Ji Che, Yinying Sun, Yixu Deng, et al.
Fluids and Barriers of the CNS (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 14
The Associations of Phosphorylated Tau 181 and Tau 231 Levels in Plasma and Cerebrospinal Fluid with Cognitive Function in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Zhirui Li, Zixuan Fan, Qian Zhang
Journal of Alzheimer s Disease (2024) Vol. 98, Iss. 1, pp. 13-32
Closed Access | Times Cited: 12
Blood–brain barrier alterations and their impact on Parkinson’s disease pathogenesis and therapy
Kristina Lau, Rebecca Kotzur, Franziska Richter
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Gain-of-function mutations of TRPV4 acting in endothelial cells drive blood-CNS barrier breakdown and motor neuron degeneration in mice
Jeremy M. Sullivan, Anna M. Bagnell, Jonathan Alevy, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 748
Open Access | Times Cited: 10
Plasma brain-related biomarkers and potential therapeutic targets in pediatric ECMO
Sue J. Hong, Bradley J. De Souza, Kristen K. Penberthy, et al.
Neurotherapeutics (2025) Vol. 22, Iss. 1, pp. e00521-e00521
Closed Access | Times Cited: 1
Imaging subtle leaks in the blood–brain barrier in the aging human brain: potential pitfalls, challenges, and possible solutions
Axel Montagne, Samuel Barnes, Daniel A. Nation, et al.
GeroScience (2022) Vol. 44, Iss. 3, pp. 1339-1351
Open Access | Times Cited: 37
Targeting the blood–brain barrier to delay aging-accompanied neurological diseases by modulating gut microbiota, circadian rhythms, and their interplays
Yanping Wang, Weihong Du, Xiaoyan Hu, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 12, pp. 4667-4687
Open Access | Times Cited: 20
Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier
Kassandra Kisler, Abhay P. Sagare, Divna Lazić, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 16
Dietary Polyphenols as a Protection against Cognitive Decline: Evidence from Animal Experiments; Mechanisms and Limitations
Ruth Naomi, Muhammad Dain Yazid, Soo Huat Teoh, et al.
Antioxidants (2023) Vol. 12, Iss. 5, pp. 1054-1054
Open Access | Times Cited: 16
Oligomeric Tau-induced oxidative damage and functional alterations in cerebral endothelial cells: Role of RhoA/ROCK signaling pathway
Faruk Hossen, Grace Y. Sun, James C. Lee
Free Radical Biology and Medicine (2024) Vol. 221, pp. 261-272
Open Access | Times Cited: 6
Immune system-wide Mendelian randomization and triangulation analyses support autoimmunity as a modifiable component in dementia-causing diseases
Joni V. Lindbohm, Nina Mars, Pyry N. Sipilä, et al.
Nature Aging (2022) Vol. 2, Iss. 10, pp. 956-972
Open Access | Times Cited: 25
White matter injury, cholesterol dysmetabolism, and APP/Abeta dysmetabolism interact to produce Alzheimer’s disease (AD) neuropathology: A hypothesis and review
Frank R. Sharp, Charles DeCarli, Lee‐Way Jin, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 14
Integrative multi-omic profiling of adult mouse brain endothelial cells and potential implications in Alzheimer’s disease
Min Yu, Yage Nie, Jiawen Yang, et al.
Cell Reports (2023) Vol. 42, Iss. 11, pp. 113392-113392
Open Access | Times Cited: 13
Blood–brain barrier transporters: a translational consideration for CNS delivery of neurotherapeutics
Patrick T. Ronaldson, Thomas P. Davis
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 1, pp. 71-89
Closed Access | Times Cited: 5
The impact of neuroinflammation on neuronal integrity
Bora Tastan, Michael T. Heneka
Immunological Reviews (2024) Vol. 327, Iss. 1, pp. 8-32
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top